Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biotricity Inc (NQ: BTCY ) 1.009 +0.071 (+7.59%) Streaming Delayed Price Updated: 10:04 AM EDT, Jun 20, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Biotricity Inc < Previous 1 2 3 4 Next > Biotricity Launches Direct-to-Consumer Heart Health Screening Service, HeartSecure, Making Heart Health Services Accessible in Response to the #1 Global Killer, Poising Company to Access the Growing Home Diagnostics Market June 12, 2024 Via ACCESSWIRE Biotricity Provides Year-End Guidance with Expectations to Meet Analyst Revenue Target and Beating Loss and Margin Targets June 06, 2024 Via ACCESSWIRE Biotricity Preferred Shareholders Show Increased Commitment and Support of the Company by Converting Almost All Preferred A Shares into Restricted Common Stock June 04, 2024 Via ACCESSWIRE Biotricity Announces the Upcoming Launch of the First-Ever Direct-to-Patient Cardiac Screening Service, Targeting the $1.05B Home Heart Health Market May 30, 2024 Via ACCESSWIRE Biotricity Receives Health Canada Clearance for Biotres February 29, 2024 Via ACCESSWIRE Biotricity Expands Development of its Cardiac AI Cloud Platform with Data Ecosystem of over 360 billion Heartbeats January 23, 2024 Via ACCESSWIRE Biotricity to Host Second Quarter Fiscal Year 2024 Financial Results and Business Update Call on November 14th November 10, 2023 Via ACCESSWIRE CORRECTION BY SOURCE: Biotricity Announces Patent Filing for Cutting-Edge Biotres Device October 04, 2023 Via ACCESSWIRE Biotricity Expands Market Reach to Pulmonary and Neurology Fields Through Latest Partnerships with Two Leading Home-Based Diagnostic Companies April 30, 2024 Via ACCESSWIRE Biotricity's Path Towards Breakeven Accelerated by Latest Diagnostic Product, Biotres Pro, Garnering Rapid Interest from Existing and New Customers April 26, 2024 Via ACCESSWIRE Biotricity Launches Major Cardiac Monitoring Pilot Program in a Hospital System Comprised of 9 Hospitals and 10 Clinics April 18, 2024 Via ACCESSWIRE Biotricity Launches Cardiac Monitoring Pilot Program with Major Hospital Network April 16, 2024 Via ACCESSWIRE Biotricity Unveils a New Digital Presence, Highlighting its Expanding Technology Portfolio and Cutting-Edge Innovations September 13, 2023 Via ACCESSWIRE Biotricity Achieves $14 Million Revenue Run Rate in August 2023 August 30, 2023 Via ACCESSWIRE Biotricity Shows Continued Growth and Strength in its Fundamentals on its Path to Profitability August 11, 2023 Via ACCESSWIRE Biotricity Announces a Strategic Partnership for Cardiac Screenings in Patients with Co-Morbidities April 02, 2024 Via ACCESSWIRE LOBO EV and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV March 28, 2024 Via ACCESSWIRE Biotricity Accelerates Market Access by Partnering with Third Major Group Purchasing Organization, Expanding Market Reach to 90% of U.S. Hospitals March 28, 2024 Via ACCESSWIRE Biotricity Partners with Health Aid Africa to Provide Complementary Heart Health Screenings at Allegiant Stadium Concert March 21, 2024 Via ACCESSWIRE Biotricity Unveils that Improved Margins Resulted from Latest Advancements to its Proprietary Cardiac AI Cloud Platform and Announces Plans for Continued Expansion of its Cardiac AI Cloud March 12, 2024 Via ACCESSWIRE Biotricity Partners with a Second Top Group Purchasing Organization - Positions Company for Expanded Market Access to 1 out of every 2 Hospitals in America March 05, 2024 Via ACCESSWIRE Biotricity Strengthens its Foundation for Growth, Achieves Lower Cost of Sales, Expanding Margins of 73% and Increased Device Sales, for Third Quarter of Fiscal Year 2024 February 21, 2024 Via ACCESSWIRE Biotricity to Host Third Quarter Fiscal Year 2024 Financial Results and Business Update Call on February 21st February 19, 2024 Via ACCESSWIRE Biotricity Advances Towards Breakeven Milestone - Set to Announce Record Margins and Operational Efficiency for Third Quarter of Fiscal Year 2024 February 14, 2024 Via ACCESSWIRE Biotricity Delivers Record Margins and Double Digit Year-Over-Year Sales Growth for Second Quarter of Fiscal Year 2024 November 14, 2023 Via ACCESSWIRE Biotricity Releases Another Groundbreaking Product: Biotres Pro October 31, 2023 Via ACCESSWIRE Biotricity Continues to Expand Patent Portfolio with Latest Patent Filing for Bioheart Device October 10, 2023 Via ACCESSWIRE Biotricity Announces Patient Filing for Cutting-Edge Biotres Device October 03, 2023 Via ACCESSWIRE Biotricity Reports Strong Growth for its First Quarter Fiscal Year 2024 and Provides Financial Results and Business Updates August 15, 2023 Via ACCESSWIRE Biotricity to Host First Quarter Fiscal Year 2024 Financial Results and Business Update Call on August 15th August 14, 2023 Via ACCESSWIRE < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.